Indaptus Therapeutics Inc

XNAS:INDP  
3.63
+0.08 (+2.25%)
7:50:18 PM EDT: $3.75 +0.12 (+3.31%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Indaptus Therapeutics Inc Stock, XNAS:INDP

3 Columbus Circle, 15th floor, New York, New York 10019
Israel
Phone: +1.646.427.2727
Number of Employees: 7
http://indaptusrx.com

Description

Indaptus Therapeutics, Inc. is a pre-clinical biotechnology company. It engages in the development of a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. The firm created patented treatment methods and associated patented compositions for attenuation and killing of non-pathogenic, Gram-negative bacteria. The company was founded by Michael James Newman on February 24, 2021 and is headquartered in New York, NY.